ClinicalTrials.Veeva

Menu

The Effects of Filter During CPET on WOB and Aerosol Particle Concentrations

Rush logo

Rush

Status

Terminated

Conditions

Transmission, Patient-Professional

Treatments

Other: Standard mouthpiece
Device: Respiratory filter in-line placed with the standard mouthpiece

Study type

Interventional

Funder types

Other

Identifiers

NCT04526925
CPET-001

Details and patient eligibility

About

Due to the concerns of virus transmission during COVID-19 pandemic, multiple respiratory societies postpone or limit pulmonary function test, especially cardiopulmonary exercise test (CPET), as patients may generate large amount of aerosol particles during test but it is conventionally performed without filter. This study aims to investigate the effects of reducing aerosol particle concentrations in the room air during CPET by placing an inline filter, and to assess the effects of filter on the physiologic responses during CPET.

Full description

The subject will spend two visits one hour each day (~ 1 hour) in the PFT lab and will have two separate CPET (Vmax Encore PFT System, Vyaire medical, Mettawa, IL) tests performed by registered pulmonary function technologists. One day the test will be performed with the inline filter during CPET, and the second day the CPET will be performed without a filter. During the test, electrocardiogram (ECG) electrodes will be attached to participants as well as a mask, and their heart rate will be measured for 10 minutes at rest, and then they will ride bicycle for 20 minutes at different levels of intensity. The work rate increment will be the same for both tests. All gas exchange and aerosol particle concentrations measures will be compared with Bland Altman analysis and paired t-testing.

Enrollment

10 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ages 18-65, Male or Female
  • Normal exercise tolerance without dyspnea or clinically important limitation of exercise tolerance.

Exclusion criteria

  • Complicated heart or lung disease
  • Pregnancy
  • Complex arrhythmias
  • Severe Anemia
  • Uncontrolled Diabetes, hypertension, or untreated thyroid disease
  • Has any of the following symptoms in the last 21 days: sore throat, cough, chills, body aches for unknown reasons, shortness of breath for unknown reasons, loss of smell, loss of taste, fever at or greater than 100 degrees Fahrenheit.
  • COVID-19 test positive within 21 days.
  • Any Disease that the PI feels will markedly increase the risk of CPET testing

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

10 participants in 2 patient groups

standard CPET
Active Comparator group
Description:
Standard CPET will be performed without in-line filter
Treatment:
Other: Standard mouthpiece
standard CPET with in-line filter
Experimental group
Description:
An in-line filter will be placed on the mouthpiece during standard CPET
Treatment:
Device: Respiratory filter in-line placed with the standard mouthpiece

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems